Investor's Business Daily on MSN6h
Novo Nordisk Surges As Next-Gen Obesity Drug Outperforms
Novo Nordisk stock surged Friday after the obesity kingpin reported strong results for its next-generation weight-loss drug, amycretin.
MM&M7h
Novo Nordisk’s amycretin cuts weight by 22% in early obesity trial
The Danish pharma giant posted impressive data for amycretin one month after the disappointing readout of CagriSema.
Sionna Therapeutics Seeks $100 Million in IPO For Cystic Fibrosis Treatments
Sionna Therapeutics aims to raise $100 million in an IPO for cystic fibrosis drugs, backed by venture capital, targeting a ...
Packers News11h
Vikings put a wall around quarterback Sam Darnold and the Packers couldn’t knock it down
MINNEAPOLIS – Believe it or not, the Minnesota Vikings had concerns about the Green Bay Packers getting to quarterback Sam Darnold. Yes, the same Sam Darnold who completed 33 of 43 passes for 377 ...
Viking Therapeutics: Cooling Market Sentiments Surrounding GLP1s - Much Uncertainties Ahead
Viking Therapeutics struggles with FDA approval and scaling up. Find out why VKTX stock’s path remains uncertain, despite its ...
bovnews13h
Viking Therapeutics Inc (VKTX) Stock: Surpassing Expectations in the Market?
Viking Therapeutics Inc (VKTX) stock saw a modest uptick, ending the day at $34.94 which represents a slight increase of $0.89 or 2.61% from the prior close of $34.05. The stock opened at $33.85 and ...